Cecilia P-P.A.,Seccion de Estudios de Posgrado e Investigacion de la Escuela Superior de Medicina |
Cecilia P-P.A.,Astrazeneca |
Manuel P-A.V.,CINVESTAV |
Isabel W-F.,CINVESTAV |
And 6 more authors.
Frontiers in Bioscience - Elite | Year: 2012
The relaxant effect of the lactone of rosuvastatin was evaluated on aortic rings from male Wistar rats (250- 300 g) with and without endothelium, precontracted with 1.0 μM phenylephrine. The lactone presented a greater potency than rosuvastatin in relaxing aortic rings. Unlike rosuvastatin, the effect of its lactone was endotheliumindependent. Pretreatment with either indomethacin (10 microM) or mevalonate (1 mM) did not inhibit the relaxant effect of the lactone. L-NAME (10 microM), 1400 W (10 μM), or tetraethylammonium (TEA, 10 mM) partially inhibited the relaxant effect of the lactone on endothelium-denuded aortic rings. However, cycloheximide (10 μM) or the combination of TEA plus LNAME completely inhibited the relaxant effect. The NOS- 2 was only present in endothelium-denuded aortic rings, as demonstrated by immunoblot with lactone treated rings. In conclusion, rosuvastatin was associated with a relaxant effect dependent on both endothelium and HMG-CoA reductase in rat aorta, whereas the lactone exhibited an endothelium and HMG-CoA reductase-independent relaxant effect. Both nitric oxide produced by NOS-2 and K+ channels are involved in the relaxant effect of the lactone.